other material
confidence high
sentiment positive
materiality 0.75
BriaCell reports new Phase 2 responder with 3-cycle orbital tumor resolution after 7 prior failed regimens
BriaCell Therapeutics Corp.
- Patient with proptosis from orbital metastatic breast cancer had remarkable improvement and pain reduction after 3 cycles of Bria-IMT combo.
- Heavily pretreated patient had failed 7 prior regimens; continues treatment with well-tolerated regimen.
- Second reported case of orbital tumor resolution; first patient had failed 12 regimens and 16 agents.
- Additional Phase 2 survival updates and clinical data to be presented at San Antonio Breast Cancer Symposium Dec 6-7, 2023.